Your browser doesn't support javascript.
loading
Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure.
Fisher, Caleb; Patel, Vishal C; Stoy, Sidsel Hyldgaard; Singanayagam, Arjuna; Adelmeijer, Jelle; Wendon, Julia; Shawcross, Debbie L; Lisman, Ton; Bernal, William.
Afiliación
  • Fisher C; Liver Intensive Care Unit, Institute of Liver Studies, King College Hospital, London, United Kingdom. Electronic address: Caleb.fisher@nhs.net.
  • Patel VC; Liver Intensive Care Unit, Institute of Liver Studies, King College Hospital, London, United Kingdom.
  • Stoy SH; Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Singanayagam A; Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Adelmeijer J; Surgical Research Laboratory, University Medical Center Groningen, Groningen, Netherlands.
  • Wendon J; Liver Intensive Care Unit, Institute of Liver Studies, King College Hospital, London, United Kingdom.
  • Shawcross DL; Institute of Liver Studies, Kings College Hospital, London, United Kingdom.
  • Lisman T; Surgical Research Laboratory, University Medical Center Groningen, Groningen, Netherlands.
  • Bernal W; Liver Intensive Care Unit, Institute of Liver Studies, King College Hospital, London, United Kingdom. Electronic address: william.bernal@kcl.ac.uk.
J Crit Care ; 43: 54-60, 2018 Feb.
Article en En | MEDLINE | ID: mdl-28843665
ABSTRACT

BACKGROUND:

Cirrhotic patients have complex haemostatic abnormalities. Current evidence suggests stable cirrhotic (SC) patients have a "re-balanced" haemostatic state. However, limited data exists in acute decompensated (AD) or acute on chronic liver failure (ACLF) patients.

METHODS:

We utilised thrombin generation analysis, fibrinolysis assessment, and evaluation of haemostatic parameters to assess haemostasis in liver disease of progressive severity.

RESULTS:

The study cohorts were comprised of SC, n=8; AD n=44; ACLF, n=17; and Healthy Control (HC), n=35. There was a progressive increase across the cohorts in INR (p=0.0001), Factor VIII (p=0.0001) and VWF levels (p=0.0001) and a correspondingly decrease in anti-thrombin (p=0.0001), ADAMTS-13 (p=0.01) and fibrinogen levels (p=0.0001). In the presence of thrombomodulin, thrombin generation was equivalent or significantly higher in all the cohorts compared to HC (p=0.0001). Compared to AD, ACLF had a lower ETP (p=0.002) and thrombin peak (p=0.0001). There was no significant difference across the cohorts in clot lysis time (p=0.07), although compared to HC, AD had a significantly shorter lysis time (p=0.001).

CONCLUSIONS:

Our cohorts, despite significant differences in haemostatic parameters, displayed intact thrombin generation but progressive hypo-functional clot stability and potentially but not universal hyper-functional haemostasis.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Crítica / Insuficiencia Hepática Crónica Agudizada / Hemostasis Tipo de estudio: Observational_studies Idioma: En Revista: J Crit Care Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad Crítica / Insuficiencia Hepática Crónica Agudizada / Hemostasis Tipo de estudio: Observational_studies Idioma: En Revista: J Crit Care Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article